Irvine Scientific Introduces PRIME-XV T Cell CDM for Immunotherapy Applications
Irvine Scientific, a worldwide leader in cell culture media development and manufacturing announced the introduction of PRIME-XV T Cell CDM, ...
Irvine Scientific, a worldwide leader in cell culture media development and manufacturing announced the introduction of PRIME-XV T Cell CDM, ...
VistaGen Therapeutics Inc , a clinical-stage biopharmaceutical company focused on developing new generation therapies for depression and other central nervous ...
Now combining DNA synthesis, protein expression and protein engineering capabilities, ATUM delivers full suite of service to speed discovery Founded in ...
Dr. Reddy’s Laboratories Ltd announced that it has launched Nystatin and Triamcinolone Acetonide Cream, USP, in the United States market, ...
Prima BioMed Ltd and WuXi Biologics ,a WuXi AppTec group company, and a leading open-access R&D capability and technology platform ...
Novo Nordisk A/S said the U.S. FDA approved on Monday its diabetes drug, Xultophy.The Danish drug maker said it planned ...
Shire plc announced that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing ...
Absorption Systems, a world leader in novel test systems for drug transporters, announces the renewal of a technology licensing deal ...
Sandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...
PCI Services are pleased to announce that we are extending our current Cryogenic storage capabilities to our Rockford , Illinois ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.